Sri Dhanada Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 09-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 09-12-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 1.00 Cr
as on 09-12-2024
- Revenue -63.85%
(FY 2017)
- Profit -69.75%
(FY 2017)
- Ebitda -10.56%
(FY 2017)
- Net Worth -41.54%
(FY 2017)
- Total Assets -25.19%
(FY 2017)
About Sri Dhanada Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Raghuram Namireddy and Rajarami Namireddy serve as directors at the Company.
- CIN/LLPIN
U24232TG2010PTC066994
- Company No.
066994
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 2010
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sri Dhanada Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghuram Namireddy  | Director | 11-Feb-2010 | Current |
| Rajarami Namireddy | Director | 11-Feb-2010 | Current |
Financial Performance and Corporate Structure Insights of Sri Dhanada Laboratories.
Sri Dhanada Laboratories Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 63.85% decrease. The company also saw a substantial fall in profitability, with a 69.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Dhanada Laboratories?
In 2017, Sri Dhanada Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prakjyothi Constructions Private LimitedActive 17 years 5 monthsRaghuram Namireddy and Rajarami Namireddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allhabad Bank Creation Date: 21 Nov 2013 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Sri Dhanada Laboratories?
Unlock and access historical data on people associated with Sri Dhanada Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Dhanada Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Dhanada Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
